Conversion to prolonged-release tacrolimus for pediatric living related donor liver transplant recipients

Transplantation Proceedings

Volumn 45, Issue 5, 2013, Pages 1975-1978

  Ueno, T ^a   Takama, Y ^a   Masahata, K ^a   Uehara, S ^a   Ibuka, S ^a   Kondou, H ^a   Hasegawa, Y ^a   Fukuzawa, M ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONFERENCE PAPER; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; PATIENT SATISFACTION; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT RESPONSE;

CHILD; CHILD, PRESCHOOL; FAMILY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; LIVING DONORS; MALE; TACROLIMUS;

EID: 84879216122     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.02.111     Document Type: Conference Paper

References (3)

1. T. Ueno, N. Tanaka, Y. Ihara Graft fibrosis in patients with biliary atresia after pediatric living-related liver transplantation Pediatr Transplant 15 5 2011 470 475
2. P. Trunea, O. Boillot, D. Seehofer Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation Am J Transplant 10 10 2010 2313 2323
3. S. Beckebaum, S. Iacob, D. Sweid Efficacy, safety, and immunosuppressant adherence in stable liver transplant patients converted from a twice-daily tacrolimus-based regimen to once-daily tacrolimus extended-release formulation Transpl Int 24 7 2011 666 675